Actions Life Science SMBs Can Take to Reduce The High Cost of Licensing Fraud

In life sciences and biotech, missed royalties can severely impact R&D and deter investors. Companies often rely on manual reporting, increasing fraud risks. Licensing compliance is crucial for commercial success. Implementing system-generated reports, clear contracts, and auditing rights can enhance revenue verification and operational integrity, protecting the business’s future. Continue reading